berberine has been researched along with Weight Loss in 6 studies
Weight Loss: Decrease in existing BODY WEIGHT.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study provides a critical overview of experimental studies in vitro, in humans, and in animals that evaluated the efficacy of Berberine and its effect on management of obesity and the related metabolic consequences." | 9.05 | The effect of Berberine on weight loss in order to prevent obesity: A systematic review. ( Al-Thawadi, S; Alalwan, TA; Gasparri, C; Ilyas, Z; Infantino, V; Perna, S; Peroni, G; Petrangolini, G; Riva, A; Rondanelli, M, 2020) |
| "This study provides a critical overview of experimental studies in vitro, in humans, and in animals that evaluated the efficacy of Berberine and its effect on management of obesity and the related metabolic consequences." | 5.05 | The effect of Berberine on weight loss in order to prevent obesity: A systematic review. ( Al-Thawadi, S; Alalwan, TA; Gasparri, C; Ilyas, Z; Infantino, V; Perna, S; Peroni, G; Petrangolini, G; Riva, A; Rondanelli, M, 2020) |
| "Berberine was administered through gavage to C57BL/6 mice with established CDI-induced intestinal injury and colitis." | 1.42 | Berberine blocks the relapse of Clostridium difficile infection in C57BL/6 mice after standard vancomycin treatment. ( Liu, W; Lv, Z; Peng, G; Su, J; Xu, H, 2015) |
| "Berberine treatment resulted in increased AMP-activated protein kinase (AMPK) activity in 3T3-L1 adipocytes and L6 myotubes, increased GLUT4 translocation in L6 cells in a phosphatidylinositol 3' kinase-independent manner, and reduced lipid accumulation in 3T3-L1 adipocytes." | 1.33 | Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. ( Cho, HJ; Gosby, A; Hohnen-Behrens, C; James, DE; Kim, CT; Kim, JB; Kim, KH; Kim, WS; Kraegen, EW; Lee, CH; Lee, YS; Oh, WK; Shen, Y; Ye, JM; Yoon, MJ, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Amini, MR | 1 |
| Sheikhhossein, F | 1 |
| Naghshi, S | 1 |
| Djafari, F | 1 |
| Askari, M | 1 |
| Shahinfar, H | 1 |
| Safabakhsh, M | 1 |
| Jafari, A | 1 |
| Shab-Bidar, S | 1 |
| Ilyas, Z | 1 |
| Perna, S | 1 |
| Al-Thawadi, S | 1 |
| Alalwan, TA | 1 |
| Riva, A | 1 |
| Petrangolini, G | 1 |
| Gasparri, C | 1 |
| Infantino, V | 1 |
| Peroni, G | 1 |
| Rondanelli, M | 1 |
| Lv, Z | 1 |
| Peng, G | 1 |
| Liu, W | 1 |
| Xu, H | 1 |
| Su, J | 1 |
| Hu, Y | 1 |
| Ehli, EA | 1 |
| Kittelsrud, J | 1 |
| Ronan, PJ | 1 |
| Munger, K | 1 |
| Downey, T | 1 |
| Bohlen, K | 1 |
| Callahan, L | 1 |
| Munson, V | 1 |
| Jahnke, M | 1 |
| Marshall, LL | 1 |
| Nelson, K | 1 |
| Huizenga, P | 1 |
| Hansen, R | 1 |
| Soundy, TJ | 1 |
| Davies, GE | 1 |
| Lee, YS | 1 |
| Kim, WS | 1 |
| Kim, KH | 1 |
| Yoon, MJ | 1 |
| Cho, HJ | 1 |
| Shen, Y | 1 |
| Ye, JM | 1 |
| Lee, CH | 1 |
| Oh, WK | 1 |
| Kim, CT | 1 |
| Hohnen-Behrens, C | 1 |
| Gosby, A | 1 |
| Kraegen, EW | 1 |
| James, DE | 1 |
| Kim, JB | 1 |
| Iizuka, N | 1 |
| Hazama, S | 1 |
| Yoshimura, K | 1 |
| Yoshino, S | 1 |
| Tangoku, A | 1 |
| Miyamoto, K | 1 |
| Okita, K | 1 |
| Oka, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Therapeutic Effects of Combination of Insulin With Berberine on the Patients With Stess Hyperlipemia:a Prospective, Double Blind, Randomized, Placebo-controlled, Single-center Clinical Trial[NCT02806999] | Phase 4 | 200 participants (Anticipated) | Interventional | 2016-07-31 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for berberine and Weight Loss
| Article | Year |
|---|---|
Effects of berberine and barberry on anthropometric measures: A systematic review and meta-analysis of randomized controlled trials.
Topics: Anthropometry; Berberine; Berberis; Humans; Randomized Controlled Trials as Topic; Weight Loss | 2020 |
The effect of Berberine on weight loss in order to prevent obesity: A systematic review.
Topics: Adipocytes; Berberine; Blood Glucose; Cholesterol; Gastrointestinal Microbiome; Gluconeogenesis; Hum | 2020 |
1 trial available for berberine and Weight Loss
| Article | Year |
|---|---|
Lipid-lowering effect of berberine in human subjects and rats.
Topics: Adult; Animals; Berberine; Calcitriol; Cholesterol; Coptis; Drugs, Chinese Herbal; Female; Humans; H | 2012 |
3 other studies available for berberine and Weight Loss
| Article | Year |
|---|---|
Berberine blocks the relapse of Clostridium difficile infection in C57BL/6 mice after standard vancomycin treatment.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Base Sequence; Berberine; Clos | 2015 |
Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states.
Topics: 3T3-L1 Cells; Adipocytes; Adipose Tissue; AMP-Activated Protein Kinases; Animals; Berberine; Cell Li | 2006 |
Anticachectic effects of the natural herb Coptidis rhizoma and berberine on mice bearing colon 26/clone 20 adenocarcinoma.
Topics: Adenocarcinoma; Adipose Tissue; Animals; Berberine; Cachexia; Colonic Neoplasms; Coptis chinensis; D | 2002 |